Logo image of QTI

QT IMAGING HOLDINGS INC (QTI) Stock Fundamental Analysis

NASDAQ:QTI - Nasdaq - US7469621095 - Common Stock - Currency: USD

0.3951  -0.12 (-22.82%)

After market: 0.3501 -0.04 (-11.39%)

Fundamental Rating

0

Taking everything into account, QTI scores 0 out of 10 in our fundamental rating. QTI was compared to 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of QTI have multiple concerns. QTI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QTI had negative earnings in the past year.
QTI had a negative operating cash flow in the past year.
QTI Yearly Net Income VS EBIT VS OCF VS FCFQTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M -4M

1.2 Ratios

With a Return On Assets value of -214.42%, QTI is not doing good in the industry: 91.58% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -214.42%
ROE N/A
ROIC N/A
ROA(3y)-8.1%
ROA(5y)N/A
ROE(3y)-15.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QTI Yearly ROA, ROE, ROICQTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QTI Yearly Profit, Operating, Gross MarginsQTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

QTI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for QTI is higher compared to a year ago.
QTI Yearly Shares OutstandingQTI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
QTI Yearly Total Debt VS Total AssetsQTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -10.66, we must say that QTI is in the distress zone and has some risk of bankruptcy.
QTI's Altman-Z score of -10.66 is on the low side compared to the rest of the industry. QTI is outperformed by 81.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.66
ROIC/WACCN/A
WACCN/A
QTI Yearly LT Debt VS Equity VS FCFQTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.06 indicates that QTI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.06, QTI is doing worse than 89.47% of the companies in the same industry.
A Quick Ratio of 0.48 indicates that QTI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.48, QTI is doing worse than 93.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.48
QTI Yearly Current Assets VS Current LiabilitesQTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

QTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.06%.
EPS 1Y (TTM)-41.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QTI Yearly Revenue VS EstimatesQTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
QTI Yearly EPS VS EstimatesQTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTI Price Earnings VS Forward Price EarningsQTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTI Per share dataQTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QT IMAGING HOLDINGS INC

NASDAQ:QTI (1/27/2025, 8:22:34 PM)

After market: 0.3501 -0.04 (-11.39%)

0.3951

-0.12 (-22.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-20 2025-03-20
Inst Owners7.3%
Inst Owner Change0%
Ins Owners13.44%
Ins Owner Change77.16%
Market Cap8.63M
AnalystsN/A
Price TargetN/A
Short Float %1.87%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.18
BVpS-0.44
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -214.42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8.1%
ROA(5y)N/A
ROE(3y)-15.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.48
Altman-Z -10.66
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-372.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-370.65%
OCF growth 3YN/A
OCF growth 5YN/A